Healthy adults
Conditions
Sponsors
Kirin company
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: (1)Individuals aged from 20 to 65 years, when giving the informed consent. (2)Individuals who are aware of eye strain. (3)Individuals giving the written informed consent.
Exclusion criteria
Exclusion criteria: (1)Individuals who use medication or supplements or functional foods affecting eye strain. (2)Individuals who is not suitable for subjects by pre-test questionnaire. (3)Individuals who declare the allergy symptoms against test diets. (4)Individuals who have a chronic disease and use medicines continuously, or have a history of chronic disease. (5)Individuals who have a history of serious disease (e.g., diabetes, liver disease, kidney disease, and/or heart disease), thyroid gland disease, adrenal gland disease, and/or metabolic disorder, or have a history of these disease. (6)Individuals who have a history of digestive disease affecting digestion and absorption. (7)Individuals who have ophthalmologic disease, or have a history of ophthalmologic disease. (8)Individuals who is not suitable for subjects by pre-test. (9)Individuals who are planned to participate in other clinical study. (10)Individuals who have donated over 200 mL of blood and/or blood component within the last one month prior to the current study or over 400 mL of blood and/or blood component within the last three months prior to the current study. (11)Individuals with excessive alcohol-drinking behaviors. (12)Individuals who can't stop drinking for the days before the pre-check day and check days. (13)Individuals who have under treatment or a history of drug addiction and/or alcoholism. (14)Individuals who are planned to become pregnant after informed consent for the current study or are pregnant or lactating. (15)Individuals who are judged as unsuitable for the study by the investigator for other reason.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| High Frequency Component 1 | — |
Secondary
| Measure | Time frame |
|---|---|
| Visual Analogue Scale questionnaire | — |
Countries
Japan
Contacts
Public ContactMasao Matsuoka
HUMA R&D CORP Clinical Development Division
Outcome results
None listed